Horizon Pharma plc Named One of the Best Small & Medium Workplaces by FORTUNE and Great Place to Work® for the Second Year i...
October 17 2017 - 8:30AM
Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company
focused on improving patients' lives by identifying, developing,
acquiring and commercializing differentiated and accessible
medicines that address unmet medical needs, today announced that it
has been named one of the 2017 Best Small & Medium Workplaces
by FORTUNE and Great Place to Work® for the second year in a row.
Horizon ranked #23 on the Best Medium Workplaces List.
“It is an honor to again be recognized by FORTUNE and Great
Place to Work® as one of their Best Medium Workplaces,” said
Timothy P. Walbert, chairman, president and chief executive
officer, Horizon Pharma plc. “At Horizon, we motivate our employees
to build meaningful careers. We believe that when our team is
inspired to do more, they live up to their potential and ultimately
help patients live up to theirs. For our employees, working at
Horizon isn’t just a job – it’s personal.”
The Best Small & Medium Workplaces is one of a series of
rankings by Great Place to Work and FORTUNE based on research into
employee feedback from Great Place to Work-Certified™
organizations. Horizon also was ranked as a Best Medium Workplace
in Chicago (2017), Best Workplace in Health Care (2017) and Best
Small and Medium Workplace (2016) by FORTUNE and Great Place to
Work.
This ranking considered 74,000 surveys from employees at
hundreds of businesses in all sectors of the economy. Horizon
earned a spot on the list based on co-workers’ anonymous assessment
of the camaraderie, leadership, fairness, rewards and career
opportunities.
About Horizon Pharma plc Horizon Pharma plc is
a biopharmaceutical company focused on improving patients' lives by
identifying, developing, acquiring and commercializing
differentiated and accessible medicines that address unmet medical
needs. The Company markets 11 medicines through its orphan,
rheumatology and primary care business units. For more information,
please visit www.horizonpharma.com. Follow @HZNPplc on Twitter
and Facebook and view careers on LinkedIn.
MethodologyThe ranking was based on anonymous
feedback from more than 74,000 employees working at Great Place to
Work-Certified organizations. Employees completed a Trust Index™
survey with more than 50 questions assessing pride, camaraderie,
executive effectiveness, innovation, benefits, professional
development and other elements of a great workplace. Scores also
considered organizations’ performance relative to their size and
industry, as well as their ability to provide a great workplace for
all employees, regardless of who they are or what they do. Survey
results from eligible companies had a 6 percent margin of error, at
most, with a 95 percent confidence level. Organizations with 10 to
99 employees were considered for the small workplaces list and
those with 100-999 employees were considered for the medium
list.
To find out more about becoming Great Place to Work-Certified
and eligible for Best Workplaces lists published with FORTUNE,
visit Greatplacetowork.com.
About Great Place to Work® Great Place to Work
is the global authority on high-trust, high-performance workplace
cultures. Through its certification programs, Great Place to Work
recognizes outstanding workplace cultures and produces the annual
FORTUNE "100 Best Companies to Work For®" and Great Place to Work
Best Workplaces lists for Millennials, women, diversity, industries
and, internationally, countries and regions. Through
its culture consulting services, Great Place to Work helps its
clients create great workplaces that outpace peers on key business
metrics like revenue growth, profitability, retention and stock
performance.
Follow Great Place to Work at Greatplacetowork.com and
@GPTW_US.
Contacts:Geoff CurtisSenior Vice President,
Corporate Affairs and Chief Communications
Officergcurtis@horizonpharma.com
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Sep 2023 to Sep 2024